ID   TK [Human brain lymphoma]
AC   CVCL_E941
SY   Tk
DR   BioSample; SAMN03472435
DR   JCRB; JCRB1206
DR   JCRB; NIHS0524
DR   Wikidata; Q54972514
RX   PubMed=6450513;
RX   PubMed=7059907;
RX   PubMed=30993483;
RX   PubMed=31510952;
CC   Population: Japanese.
CC   Doubling time: 34 hours (PubMed=7059907).
CC   Anecdotal: Cell line name corresponds to the initials of the patient.
CC   Discontinued: JCRB; NIHS0524; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): JCRB=JCRB1206
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 9,10
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C9301; Central nervous system lymphoma
DI   ORDO; Orphanet_46135; Primary central nervous system lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
RX   PubMed=6450513; DOI=10.18926/AMO/30542;
RA   Miyamoto K., Miyano K., Tabuchi K., Nishimoto A., Yoshida H.,
RA   Yumoto T., Tanaka T.;
RT   "Chromosome analysis of a brain malignant lymphoma cell line.";
RL   Acta Med. Okayama 34:117-122(1980).
//
RX   PubMed=7059907; DOI=10.1002/1097-0142(19820201)49:3<456::AID-CNCR2820490311>3.0.CO;2-K;
RA   Miyoshi I., Kubonishi I., Yoshimoto S., Hikita T., Dabasaki H.,
RA   Tanaka T., Kimura I., Tabuchi K., Nishimoto A.;
RT   "Characteristics of a brain lymphoma cell line derived from primary
RT   intracranial lymphoma.";
RL   Cancer 49:456-459(1982).
//
RX   PubMed=30993483; DOI=10.1007/s10147-019-01451-9;
RA   Hayano A., Takashima Y., Yamanaka R.;
RT   "Cell-type-specific sensitivity of bortezomib in the
RT   methotrexate-resistant primary central nervous system lymphoma
RT   cells.";
RL   Int. J. Clin. Oncol. 24:1020-1029(2019).
//
RX   PubMed=31510952; DOI=10.1186/s12885-019-6129-8; PMCID=PMC6739943;
RA   Takashima Y., Yoshimura T., Kano Y., Hayano A., Hondoh H., Ikenaka K.,
RA   Yamanaka R.;
RT   "Differential expression of N-linked oligosaccharides in
RT   methotrexate-resistant primary central nervous system lymphoma
RT   cells.";
RL   BMC Cancer 19:910.1-910.11(2019).
//